Drygin Denis 4
4 · Regulus Therapeutics Inc. · Filed Aug 5, 2020
Insider Transaction Report
Form 4
Drygin Denis
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-03+300,000→ 300,000 totalExercise: $0.69Exp: 2030-08-02→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]Twenty-Five percent of the options will vest on the one year anniversary date of the grant and the balance of the shares will vest in a series of thirty-six equal monthly installments thereafter, such that the option is fully vested on the fourth anniversary of the date of grant.